Abstract
Compound-protein interactions (CPIs) are critical in drug discovery for identifying therapeutic targets, drug side effects, and repurposing existing drugs.Machine learning (ML) algorithms have emerged aspowerful toolsforCPI prediction, offering notable advantages in cost-effectiveness and efficiency. This reviewprovides an overview of recent advances in both structure-based andnon-structure-based CPI prediction ML models, highlighting their performance and achievements. It alsooffers insights into CPI prediction-related datasets andevaluation benchmarks. Lastly, the article presents acomprehensive assessment of the current landscape of CPI prediction, elucidating the challenges faced and outlining emerging trends to advance the field.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.